Pfizer is seeking FDA approval for a new RSV vaccine that just completed Phase III clinical trials. The vaccine would be given to pregnant mothers prior to delivery.
Pfizer is seeking FDA approval for a new RSV vaccine that just completed Phase III clinical trials. The vaccine would be given to pregnant mothers prior to delivery.